Lars M Koenig (Lars M König)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Topics

Long Non Coding Rna

Capillary Electrophoresis

Dendritic Cells

Top Venues

Science immunology

Cancer immunology, immunotherapy : CII

Nature biomedical engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel F R Boehmer, Simone Formisano, Carina C de Oliveira Mann, Stephan A Müller, Michael Kluge, Philipp Metzger, Meino Rohlfs, Christine Hörth, Lorenz Kocheise, Stefan F Lichtenthaler, Karl-Peter Hopfner, Stefan Endres, Simon Rothenfußer, Caroline C Friedel, Peter Duewell, Max Schnurr, Lars M Koenig
OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosis. Science immunology 6 (61) (2022)
Thomas Magg, Tsubasa Okano, Lars M Koenig, Daniel F R Boehmer, Samantha L Schwartz, Kento Inoue, Jennifer Heimall, Francesco Licciardi, Julia Ley-Zaporozhan, Ronald M Ferdman, Andrés Caballero Garcia de Oteyza, Esther N Park, Brenda M Calderon, Debayan Dey, Hirokazu Kanegane, Kazutoshi Cho, Davide Montin, Karl Reiter, Matthias Griese, Michael H Albert, Meino Rohlfs, Paul Gray, Christoph Walz, Graeme L Conn, Kathleen E Sullivan, Christoph Klein, Tomohiro Morio, Fabian H Hauck
Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency. Science immunology 6 (60) (2022)
Stefanie Lesch, Viktoria Blumenberg, Stefan Stoiber, Adrian Gottschlich, Justyna Ogonek, Bruno Loureiro Cadilha, Zahra Dantes, Felicitas Rataj, Klara Dorman, Johannes Lutz, Clara H Karches, Constanze Heise, Mathias Kurzay, Benjamin M Larimer, Simon Grassmann, Moritz Rapp, Alessia Nottebrock, Stephan Kruger, Nicholas Tokarew, Philipp Metzger, Christine Hoerth, Mohamed-Reda Benmebarek, Dario Dhoqina, Ruth Grünmeier, Matthias Seifert, Arman Oener, Öykü Umut, Sandy Joaquina, Lene Vimeux, Thi Tran, Thomas Hank, Taisuke Baba, Duc Huynh, Remco T A Megens, Klaus-Peter Janssen, Martin Jastroch, Daniel Lamp, Svenja Ruehland, Mauro Di Pilato, Jasper N Pruessmann, Moritz Thomas, Carsten Marr, Steffen Ormanns, Anna Reischer, Michael Hristov, Eric Tartour, Emmanuel Donnadieu, Simon Rothenfußer, Peter Duewell, Lars M Koenig, Max Schnurr, Marion Subklewe, Andrew S Liss, Niels Halama, Maximilian Reichert, Thorsten R Mempel, Stefan Endres, Sebastian Kobold
T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours. Nature biomedical engineering 5 (11) (2021)
Philipp Metzger, Sabrina V Kirchleitner, Daniel F R Boehmer, Christine Hörth, Angelika Eisele, Steffen Ormanns, Matthias Gunzer, Maciej Lech, Kirsten Lauber, Stefan Endres, Peter Duewell, Max Schnurr, Lars M Koenig
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model. Cancer immunology, immunotherapy : CII 69 (10) (2020)
Mike W Helms, Kerstin Jahn-Hofmann, Felix Gnerlich, Christiane Metz-Weidmann, Monika Braun, Gabriele Dietert, Petra Scherer, Kaj Grandien, Joachim Theilhaber, Hui Cao, Timothy R Wagenaar, Max M Schnurr, Stefan Endres, Dmitri Wiederschain, Sabine Scheidler, Simon Rothenfußer, Bodo Brunner, Lars M Koenig
Utility of the RIG-I Agonist Triphosphate RNA for Melanoma Therapy. Molecular cancer therapeutics 18 (12) (2019)
Michael Ruzicka, Lars M Koenig, Simone Formisano, Daniel F R Boehmer, Binje Vick, Eva-M Heuer, Hanna Meinl, Lorenz Kocheise, Marcus Zeitlhöfler, Julia Ahlfeld, Sebastian Kobold, Stefan Endres, Marion Subklewe, Peter Duewell, Max Schnurr, Irmela Jeremias, Felix S Lichtenegger, Simon Rothenfußer
RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade. Leukemia 34 (4) (2019)